Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Daily Market Overview S P 500 Nasdaq Edge Higher Dow Sees Minor Loss 20260403 1 Alm Stock Poised For Growth Key Support Holds 20260401 1 Pcf Stock Analysis High Income Securities Fund 1.06 Dip To 5.62 Key Takeaways 20260403 Is Momentum Building In Verastem Vstm Stock Price At 5.63 Up 6.03 20260413 Is Old Onb Stock A Safe Investment Price At 22.43 Up 1.04 20260406 Is Invesco Ivz Stock A Market Leader Price At 23.00 Down 4.74 20260406 Is Cirrus Logic Crus Stock A Buy Now Price At 159.04 Down 0.60 20260413 Daily Market Overview S P 500 Nasdaq Edge Higher Dow Posts Slight Dip 20260408 1 Should I Sell Gladstone Gainz Stock Now Price At 23.97 Down 0.25 20260413 DFDVW DeFi Warrant warrants attract cautious trading amid limited quarterly disclosure from DeFi sector Stellantis STLA Stock Partial Split Grinds Higher 20260415 Ideal Power IPWR Stock Public Float Strengthens 20260416 MRTN Marten Transport Ltd Q4 2025 EPS beats consensus by 337 percent shares climb nearly 4 percent today FTAI Infrastructure FIP Stock Price Action Overview Smart Money Exits 20260418 ORLA Orla Mining Ltd Common Shares posts nearly 10 percent Q4 2025 EPS beat shares rise two percent on positive sentiment Invesco IIM Stock After Hours On the Radar 20260418 iShares Core SP SmallCap ETF IJR Positioned to Benefit from Shifting US Equity Capital Flows and SmallCap Valuation Rerating What XXxs fundamentals reveal about its future Loses Ground 20260506 What Pioneer PPSI is doing to protect its market share Institutional Selling 20260508 PLOW Douglas Dynamics reports 152 percent Q4 2025 EPS beat shares rise 069 percent on favorable investor reaction KD Kyndryl Holdings Q1 2026 EPS trails analyst estimates by 163 percent shares dip 063 percent in todays session Is Palmer PSBD a once in a decade opportunity 214 20260508 How Exelixis EXEL balances growth with profitability Trend Weakens 20260508 The valuation case for Sanofi ADS SNY that is hard to ignore Investor Concern 20260508